Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Bücher
Zeitschriften
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
MTZ-Fachkongress

Antriebe und Energiesysteme von morgen


Austausch von Automobil- und Energiewirtschaft

Am 14./15. Mai geht es in Chemnitz um die Mobilitätswende durch Elektro- und Wasserstofffahrzeuge.
Erweiterte Suche
Anmelden
nach oben
Sexuality Research and Social Policy
Erschienen in: Sexuality Research and Social Policy 3/2021

15.08.2020

Integrating Pre- and Post-exposure Prophylaxes Programs for HIV Prevention Guidelines in Manila, Philippines

verfasst von: Arjee J. Restar, Anthony Surace, Harry Jin, Alberto Edeza, Adedotun Ogunbajo, William C. Goedel, Alexander Adia, Susan Cu-Uvin, Don Operario

Erschienen in: Sexuality Research and Social Policy | Ausgabe 3/2021

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Introduction

Successful implementation and promotion of biomedical HIV prevention strategies like pre- and post-exposure prophylaxes (PrEP/PEP) necessitate healthcare workers possessing sufficient knowledge of and positive attitudes toward PrEP/PEP.

Methods

Using semi-structured qualitative interviews conducted between July and August 2017, we examined PrEP/PEP awareness and attitudes among 15 healthcare workers as key informants in Manila, Philippines, where HIV is a rapidly expanding national public health crisis.

Results

Most key informants had heard about PrEP (n = 11) and PEP (n = 14). High medication cost and low PrEP/PEP awareness were identified as major barriers for PrEP/PEP implementation. Others expressed concerns for viral resistance and greater risk compensation. Concerns about infrastructural issues such as problems with logistics and funding inequities were identified as potential barriers.

Conclusion

Healthcare workers demonstrated awareness of PrEP/PEP and endorsed supportive attitudes toward PrEP/PEP but raised logistic and infrastructural concerns about implementation.

Policy Implications

In order for PrEP/PEP to be feasible in the Philippines, public funding, provider education, and standardized national prescription protocols, guidelines, and policies are needed. Such recommendations and support should take into account concerns of and address prescribing barriers among future PrEP/PEP providers.
Vorheriger Artikel Systematized Review and Meta-synthesis of the Sterilization of Women with Disabilities in the Field of Social Science: from Macroeugenics to Microeugenics
Nächster Artikel Parenthood Intentions, Pathways to Parenthood, and Experiences in the Health Services of Trans People: an Exploratory Study in Portugal

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Jetzt informieren
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Baeten, J., Donnell, D., Ndase, P., Mugo, N., Campbell, J., Wangisi, J., et al. (2012). Partners PrEP study team 2012. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The New England Journal of Medicine, 367, 399–410.CrossRef
Biernacki, P., & Waldorf, D. (1981). Snowball sampling: Problems and techniques of chain referral sampling. Sociological Methods & Research, 10(2), 141–163.CrossRef
Blumenthal, J., & Haubrich, R. (2014). Risk compensation in PrEP: An old debate emerges yet again. The virtual mentor: VM, 16(11), 909–915.PubMed
Blumenthal, J., Jain, S., Krakower, D., Sun, X., Young, J., Mayer, K., et al. (2015). Knowledge is power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS and Behavior, 19(5), 802–810.CrossRef
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101.CrossRef
Brentano, F. (2012). Psychology from an empirical standpoint. Abingdon: Routledge.
Calabrese, S. K., Magnus, M., Mayer, K. H., Krakower, D. S., Eldahan, A. I., Hawkins, L. A. G., et al. (2016). Putting PrEP into practice: Lessons learned from early-adopting US providers’ firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS One, 11(6), e0157324.CrossRef
Cassell, M. M., D. T. H., Shelton, J. D., & Stanton, D. (2006). "Risk compensation: the Achilles’ heel of innovations in HIV prevention?" Bmj, 332(7541), 605–607.
Congress of the Philippines. (2018). Republic Act No. 11166. Philippine HIV and AIDS Policy Act.
Dedoose. (2015). Web application for managing, analyzing, and presenting qualitative and mixed method research data.
Deutsch, M. B., Glidden, D. V., Sevelius, J., Keatley, J., McMahan, V., Guanira, J., Kallas, E. G., Chariyalertsak, S., & Grant, R. M. (2015). HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial. The Lancet HIV, 2(12), e512–e519.CrossRef
Edelstein, Z., Salcuni, P., & Restar, A. (2016). 'Early adopters and incident PrEP prescribing in a detailing campaign, 2014–2015' Conference on retroviruses and opportunistic infections [abstract 892]. Boston, Massachusetts (pp. 22–25).
Farr, A. C., & Wilson, D. P. (2010). An HIV epidemic is ready to emerge in the Philippines. Journal of the International AIDS Society, 13(1), 16.CrossRef
Gish, R. G., Sollano Jr., J. D., Lapasaran, A., & Ong, J. P. (2016). Chronic hepatitis B virus in the Philippines. Journal of Gastroenterology and Hepatology, 31(5), 945–952.CrossRef
Gonzalez, A. (1998). The language planning situation in the Philippines. Journal of Multilingual and Multicultural Development, 19(5), 487–525.CrossRef
Grant, R. M. (2010). Antiretroviral agents used by HIV-uninfected persons for prevention: Pre-and postexposure prophylaxis. Clinical Infectious Diseases, 50(Supplement_3), S96–S101.CrossRef
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., Montoya-Herrera, O., Fernández, T., Veloso, V. G., Buchbinder, S. P., Chariyalertsak, S., Schechter, M., Bekker, L. G., Mayer, K. H., Kallás, E. G., Amico, K. R., Mulligan, K., Bushman, L. R., Hance, R. J., Ganoza, C., Defechereux, P., Postle, B., Wang, F., McConnell, J. J., Zheng, J. H., Lee, J., Rooney, J. F., Jaffe, H. S., Martinez, A. I., Burns, D. N., & Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599.CrossRef
Hiransuthikul, A., Janamnuaysook, R., Himmad, K., Kerr, S. J., Thammajaruk, N., Pankam, T., Phanjaroen, K., Mills, S., Vannakit, R., Phanuphak, P., Phanuphak, N., & iFACT Study Team. (2019). Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: The iFACT study. Journal of the International AIDS Society, 22(7), e25338.CrossRef
Krakower, D. S., & Mayer, K. H. (2016). The role of healthcare providers in the roll-out of PrEP. Current Opinion in HIV and AIDS, 11(1), 41–48.CrossRef
Liu, A. Y., Vittinghoff, E., Chillag, K., Mayer, K., Thompson, M., Grohskopf, L., et al. (2013). Sexual risk behavior among HIV-uninfected men who have sex with men (MSM) participating in a tenofovir pre-exposure prophylaxis (PrEP) randomized trial in the United States. Journal of Acquired Immune Deficiency Syndromes (1999), 64(1), 87.CrossRef
Marcus, J. L., Glidden, D. V., Mayer, K. H., Liu, A. Y., Buchbinder, S. P., Amico, K. R., McMahan, V., Kallas, E. G., Montoya-Herrera, O., Pilotto, J., & Grant, R. M. (2013). No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One, 8(12), e81997.CrossRef
Marrazzo, J., Ramjee, G., Nair, G., Palanee, T., Mkhize, B., Nakabiito, C., et al. (2013). 'Pre-exposure prophylaxis for HIV in women: Daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN 003)' 20th Conference on Retroviruses and Opportunistic infections.
Murray, K. R., Dulli, L. S., Ridgeway, K., Dal Santo, L., de Mora, D. D., Olsen, P., et al. (2017). Improving retention in HIV care among adolescents and adults in low-and middle-income countries: A systematic review of the literature. PLoS One, 12(9), e0184879.CrossRef
Owolabi, R. S., Alabi, P., Ajayi, S., Daniel, O., Ogundiran, A., Akande, T. M., & Onafowokan, T. (2012). Knowledge and practice of post-exposure prophylaxis (PEP) against HIV infection among healthcare providers in a tertiary hospital in Nigeria. Journal of the International Association of Physicians in AIDS Care, 11(3), 179–183.CrossRef
Petroll, A. E., Walsh, J. L., Owczarzak, J. L., McAuliffe, T. L., Bogart, L. M., & Kelly, J. A. (2017). PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS and Behavior, 21(5), 1256–1267.CrossRef
Podsakoff, P. M., MacKenzie, S. B., & Podsakoff, N. P. (2012). Sources of method bias in social science research and recommendations on how to control it. Annual Review of Psychology, 63, 539–569.CrossRef
Restar, A., Chan, R., Adia, A., Quilantang, M. I., Nazareno, J., Hernandez, L., et al. (2019). Prioritizing HIV services for transgender women and men who have sex with men in Manila, Philippines: An opportunity for HIV provider interventions. The Journal of the Association of Nurses in AIDS Care.
Restar, A., Nguyen, M., Nguyen, K., Adia, A., Nazareno, J., Yoshioka, E., Hernandez, L., & Operario, D. (2018). Trends and emerging directions in HIV risk and prevention research in the Philippines: A systematic review of the literature. PLoS One, 13(12), e0207663.CrossRef
Ross, A. G., Ditangco, R. A., Belimac, J. G., Olveda, R. M., Mercado, E. S., Chau, T. N., et al. (2015). The dire sexual health crisis among MSM in the Philippines: An exploding HIV epidemic in the absence of essential health services. International Journal of Infectious Diseases, 37, 6–8.CrossRef
Saunders, B., Sim, J., Kingstone, T., Baker, S., Waterfield, J., Bartlam, B., Burroughs, H., & Jinks, C. (2018). Saturation in qualitative research: Exploring its conceptualization and operationalization. Quality & Quantity, 52(4), 1893–1907.CrossRef
Tellalian, D., Maznavi, K., Bredeek, U. F., & Hardy, W. D. (2013). Pre-exposure prophylaxis (PrEP) for HIV infection: Results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care and STDs, 27(10), 553–559.CrossRef
Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Healthcare, 19(6), 349–357.CrossRef
Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., & Kapiga, S. (2012). ‘The FEM-PrEP trial of emtricitabine/tenofovir disoproxil fumarate (Truvada) among African women’ 19th Conference on retroviruses and opportunistic infections (pp. 5–8).
World Health Organization. (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization.
World Health Organization. (2016a). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for apublic health approach. Geneva: World Health Organization.
Metadaten
Titel
Integrating Pre- and Post-exposure Prophylaxes Programs for HIV Prevention Guidelines in Manila, Philippines
verfasst von
Arjee J. Restar
Anthony Surace
Harry Jin
Alberto Edeza
Adedotun Ogunbajo
William C. Goedel
Alexander Adia
Susan Cu-Uvin
Don Operario
Publikationsdatum
15.08.2020
Verlag
Springer US
Erschienen in
Sexuality Research and Social Policy / Ausgabe 3/2021
Print ISSN: 1868-9884
Elektronische ISSN: 1553-6610
DOI
https://doi.org/10.1007/s13178-020-00490-6

Weitere Artikel der Ausgabe 3/2021

Sexuality Research and Social Policy 3/2021 Zur Ausgabe

OriginalPaper

The Sexual Activity and Sexual Satisfaction of Singles in the Second Demographic Transition

OriginalPaper

Systematized Review and Meta-synthesis of the Sterilization of Women with Disabilities in the Field of Social Science: from Macroeugenics to Microeugenics

Correction

Correction to: Perceived Importance and Enjoyment of Sexuality in Late Midlife: Cohort Differences in the Longitudinal Aging Study Amsterdam (LASA)

OriginalPaper

Latent and Under-explored Determinants of Contraceptive Use in Nigeria

Correction

Correction to: The Relationship Between ‘Coming Out’ as Lesbian, Gay, or Bisexual and Experiences of Homophobic Behaviour in Youth Team Sports

OriginalPaper

Organisational Patterns of Sex Work and the Effects of the Policy Framework